Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues

Detalhes bibliográficos
Autor(a) principal: Nóbrega, Flávio Roberto
Data de Publicação: 2019
Outros Autores: Silva, Larisse Vieira, Bezerra Filho, Carlos da Silva Maia, Lima, Tamires Cardoso, Castillo, Yunierkis P., Bezerra, Daniel Pereira, Lima, Tatjana K. Souza, Sousa, Damião Pereira de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/31766
Resumo: Brazilian agencies Conselho Nacional de Desenvolvimento Cient´ıfico e Tecnol´ogico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de N´ıvel Superior (CAPES)
id CRUZ_8a069735126aee6ee710fcf9eef007e1
oai_identifier_str oai:www.arca.fiocruz.br:icict/31766
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Nóbrega, Flávio RobertoSilva, Larisse VieiraBezerra Filho, Carlos da Silva MaiaLima, Tamires CardosoCastillo, Yunierkis P.Bezerra, Daniel PereiraLima, Tatjana K. SouzaSousa, Damião Pereira de2019-02-19T16:30:11Z2019-02-19T16:30:11Z2019NÓBREGA, F. R. et al. Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues. Journal of Chemistry, p. 1-13, 2019.2090-9063https://www.arca.fiocruz.br/handle/icict/3176610.1155/2019/4785756Brazilian agencies Conselho Nacional de Desenvolvimento Cient´ıfico e Tecnol´ogico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de N´ıvel Superior (CAPES)Universidade Federal da Paraíba. Laboratory of Pharmaceutical Chemistry. João Pessoa, PB, Brazil.Universidade Federal da Paraíba. Department of Cellular and Molecular Biology. João Pessoa, PB, Brazil.Universidade Federal da Paraíba. Laboratory of Pharmaceutical Chemistry. João Pessoa, PB, Brazil.Federal University of Sergipe. Department of Pharmacy. São Cristóvão, SE, Brazil.Universidad de Las Américas. Escuela de Ciencias Físicas y Matemáticas. Quito, Ecuador.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.Universidade Federal da Paraíba. Department of Cellular and Molecular Biology. João Pessoa, PB, Brazil.Universidade Federal da Paraíba. Laboratory of Pharmaceutical Chemistry. João Pessoa, PB, Brazil.Piplartine is an alkamide found in different Piper species and possesses several biological activities, including antiparasitic properties. Thus, the aim of the present study was to evaluate a series of 32 synthetic piplartine analogues against the Leishmania amazonensis promastigote forms and establish the structure-activity relationship and 3D-QSAR of these compounds. The antileishmanial effect of the compounds was determined using the MTTmethod. Most compounds were found to be active against L. amazonensis. Among 32 assayed derivatives, compound (E)-(−)-bornyl 3-(3,4,5-trimethoxyphenyl)-acrylate exhibited the most potent antileishmanial activity (IC50 = 0.007 ± 0.008 μM, SI > 10), followed by benzyl 3,4,5-trimethoxybenzoate (IC50 = 0.025 ± 0.009 μM, SI > 3.205) and (E)-furfuryl 3-(3,4,5-trimethoxyphenyl)-acrylate (IC50 = 0.029 ± 0.007 μM, SI > 2.688). It was found that the rigid substituents contribute to increasing antiparasitic activity against L. amazonensis promastigotes. The presence of the unsaturated heterocyclic substituent in the phenylpropanoid chemical structure (furfuryl group) resulted in a bioactive derivative. Molecular simplification of benzyl 3,4,5- trimethoxybenzoate by omitting the spacer group contributed to the bioactivity of this compound. Furthermore, bornyl radical appears to be important for antileishmanial activity, since (E)-(−)-bornyl 3-(3,4,5-trimethoxyphenyl)-acrylate exhibited the most potent antileishmanial activity. These results show that some derivatives studied would be useful as prototype molecules for the planning of new derivatives with profile of antileishmanial drugs.engHindawi Publishing CorporationLeishmanioseLeishmaniose visceralDrogasAvaliação de MedicamentosPiperLeishmaniasisVisceral leishmaniasisDrugsDrug EvaluationPiperDesign, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analoguesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/31766/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALNóbrega F.R. Design, Antileishmanial Activity...2019.pdfNóbrega F.R. Design, Antileishmanial Activity...2019.pdfapplication/pdf2473999https://www.arca.fiocruz.br/bitstream/icict/31766/2/N%c3%b3brega%20F.R.%20Design%2c%20Antileishmanial%20Activity...2019.pdff8c8252f7ddb08f26e8e88201ec3b983MD52TEXTNóbrega F.R. Design, Antileishmanial Activity...2019.pdf.txtNóbrega F.R. Design, Antileishmanial Activity...2019.pdf.txtExtracted texttext/plain57336https://www.arca.fiocruz.br/bitstream/icict/31766/3/N%c3%b3brega%20F.R.%20Design%2c%20Antileishmanial%20Activity...2019.pdf.txt169f6496b9147bb9f59e4a1d8fbd8172MD53icict/317662023-03-15 14:34:17.115oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:17Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
title Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
spellingShingle Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
Nóbrega, Flávio Roberto
Leishmaniose
Leishmaniose visceral
Drogas
Avaliação de Medicamentos
Piper
Leishmaniasis
Visceral leishmaniasis
Drugs
Drug Evaluation
Piper
title_short Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
title_full Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
title_fullStr Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
title_full_unstemmed Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
title_sort Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues
author Nóbrega, Flávio Roberto
author_facet Nóbrega, Flávio Roberto
Silva, Larisse Vieira
Bezerra Filho, Carlos da Silva Maia
Lima, Tamires Cardoso
Castillo, Yunierkis P.
Bezerra, Daniel Pereira
Lima, Tatjana K. Souza
Sousa, Damião Pereira de
author_role author
author2 Silva, Larisse Vieira
Bezerra Filho, Carlos da Silva Maia
Lima, Tamires Cardoso
Castillo, Yunierkis P.
Bezerra, Daniel Pereira
Lima, Tatjana K. Souza
Sousa, Damião Pereira de
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Nóbrega, Flávio Roberto
Silva, Larisse Vieira
Bezerra Filho, Carlos da Silva Maia
Lima, Tamires Cardoso
Castillo, Yunierkis P.
Bezerra, Daniel Pereira
Lima, Tatjana K. Souza
Sousa, Damião Pereira de
dc.subject.other.pt_BR.fl_str_mv Leishmaniose
Leishmaniose visceral
Drogas
Avaliação de Medicamentos
Piper
topic Leishmaniose
Leishmaniose visceral
Drogas
Avaliação de Medicamentos
Piper
Leishmaniasis
Visceral leishmaniasis
Drugs
Drug Evaluation
Piper
dc.subject.en.pt_BR.fl_str_mv Leishmaniasis
Visceral leishmaniasis
Drugs
Drug Evaluation
Piper
description Brazilian agencies Conselho Nacional de Desenvolvimento Cient´ıfico e Tecnol´ogico (CNPq) and Coordenação de Aperfeiçoamento de Pessoal de N´ıvel Superior (CAPES)
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-02-19T16:30:11Z
dc.date.available.fl_str_mv 2019-02-19T16:30:11Z
dc.date.issued.fl_str_mv 2019
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv NÓBREGA, F. R. et al. Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues. Journal of Chemistry, p. 1-13, 2019.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/31766
dc.identifier.issn.pt_BR.fl_str_mv 2090-9063
dc.identifier.doi.pt_BR.fl_str_mv 10.1155/2019/4785756
identifier_str_mv NÓBREGA, F. R. et al. Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues. Journal of Chemistry, p. 1-13, 2019.
2090-9063
10.1155/2019/4785756
url https://www.arca.fiocruz.br/handle/icict/31766
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Hindawi Publishing Corporation
publisher.none.fl_str_mv Hindawi Publishing Corporation
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/31766/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/31766/2/N%c3%b3brega%20F.R.%20Design%2c%20Antileishmanial%20Activity...2019.pdf
https://www.arca.fiocruz.br/bitstream/icict/31766/3/N%c3%b3brega%20F.R.%20Design%2c%20Antileishmanial%20Activity...2019.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
f8c8252f7ddb08f26e8e88201ec3b983
169f6496b9147bb9f59e4a1d8fbd8172
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009063959592960